Renova Therapeutics | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
Renova Therapeutics

BRIEF

published on 06/12/2024 at 15:05, 1 year 7 months ago

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions

Diabetes Clinical Trials Gene Therapy Renova Therapeutics Heart Failure
PRESS RELEASE

published on 06/12/2024 at 15:00, 1 year 7 months ago

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions
Renova Therapeutics announces exploration of new therapeutic opportunities expanding gene therapy use for diabetes and heart failure. Clinical trials and preclinical studies show promising results

Diabetes Clinical Trials Gene Therapy Renova Therapeutics Heart Failure
BRIEF

published on 05/09/2024 at 03:05, 1 year 8 months ago

Renova Therapeutics Prioritizes Gene Therapy Development for Heart Failure and Type 2 Diabetes

Clinical Trials Gene Therapy Renova Therapeutics Heart Failure Treatment Type 2 Diabetes Treatment
PRESS RELEASE

published on 05/09/2024 at 03:00, 1 year 8 months ago

Renova Therapeutics Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus
Renova Therapeutics prioritizes two primary regulatory pathways for launching pivotal human trials of gene therapies to treat heart failure and type 2 diabetes mellitus

Clinical Trials Gene Therapy Renova Therapeutics Heart Failure Type 2 Diabetes Mellitus

Accesswire

Published on 02/07/2026 at 01:00, 1 day ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 2 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 3 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 10 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 12 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 4 hours 42 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 9 hours 6 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 9 hours 21 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 6 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 7 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 7 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 9 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 2 days 6 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 2 days 7 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 2 days 7 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE